Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction

✍ Scribed by Lyketsos, Constantine; Abushakra, Susan; Liang, Earvin; Hernandez, Ramon; Tariot, Pierre; Porsteinsson, Anton; Wagg, Jonathan

• Book ID: 122186034
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 283 KB
• Volume: 8
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.08.105